What is the recommended dose of Tamiflu (oseltamivir) for a 10-year-old pediatric patient weighing 11.6 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tamiflu Dosing for 11.6 kg, 10-Year-Old Patient

For a 10-year-old child weighing 11.6 kg, the recommended Tamiflu dose is 30 mg twice daily for treatment (5 days) or 30 mg once daily for prophylaxis (10 days), administered as 5 mL of the 6 mg/mL oral suspension. 1, 2, 3

Weight-Based Dosing Algorithm

This patient falls into the ≤15 kg weight category, which is the critical determinant for dosing regardless of age 1, 2, 3:

  • Children ≤15 kg: 30 mg per dose 1, 2, 3
  • Children >15 to 23 kg: 45 mg per dose 1, 2
  • Children >23 to 40 kg: 60 mg per dose 1, 2
  • Children >40 kg: 75 mg per dose 1, 2

The weight-based dosing takes precedence over age-based recommendations. Although this patient is 10 years old (an age where some older guidelines suggest higher doses), the 11.6 kg weight definitively places them in the lowest dosing category. 1, 2

Formulation and Administration

  • Use the oral suspension formulation at 6 mg/mL concentration 2, 3
  • Administer 5 mL of oral suspension per dose to deliver the 30 mg dose 2, 3
  • Give with food to reduce gastrointestinal side effects (nausea, vomiting), which occur in approximately 10-15% of patients 4, 5, 6
  • Use a calibrated oral dosing device that accurately measures 5 mL—never use household spoons 4, 3

Treatment vs. Prophylaxis Regimens

For treatment of influenza:

  • 30 mg (5 mL) twice daily for 5 days 1, 2, 3
  • Initiate within 48 hours of symptom onset for maximum benefit 1, 4, 7

For prophylaxis:

  • 30 mg (5 mL) once daily for 10 days (post-exposure) 1, 2, 3
  • May extend up to 6 weeks during community outbreaks 1, 3

Critical Pitfalls to Avoid

Do not round up to the next weight category. A child weighing 11.6 kg should receive 30 mg, NOT 45 mg, as they remain firmly in the ≤15 kg bracket. 2, 4 This is a common error when providers focus on age rather than weight.

Do not use age-based dosing for this patient. Some older references suggest 187.5 mg twice daily for 7-9 year olds or 250 mg twice daily for children >10 years, but these recommendations apply only to children of normal weight-for-age. 1 This 10-year-old's weight of 11.6 kg is significantly below expected (likely representing severe malnutrition, failure to thrive, or chronic illness), making weight-based dosing essential.

Do not delay treatment waiting for laboratory confirmation if influenza is clinically suspected during flu season, as efficacy decreases significantly after 48 hours. 1, 4

Complete the full 5-day treatment course even if symptoms improve earlier to prevent viral resistance and relapse. 4, 3

Special Considerations for This Underweight Patient

This child's weight is markedly below the 5th percentile for a 10-year-old (expected weight ~32 kg), suggesting underlying pathology. 2, 4 Consider:

  • Assess for chronic conditions that may increase influenza complication risk (immunosuppression, cardiac disease, pulmonary disease, metabolic disorders) 1
  • No renal dose adjustment is needed unless creatinine clearance is <30 mL/min 1, 3
  • Monitor closely for dehydration given the increased risk of gastrointestinal side effects and potentially limited reserves in an underweight child 6, 7

Safety Profile

Oseltamivir is FDA-approved for children as young as 2 weeks of age, making it safe for this 10-year-old. 1, 4, 3 The most common adverse effects are mild, transient gastrointestinal symptoms (nausea, vomiting) that are significantly reduced when administered with food. 5, 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tamiflu Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Influenza in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Neuraminidase inhibitors: zanamivir and oseltamivir.

The Annals of pharmacotherapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.